Acquisition of Radioactive products (PLUVICTO and LUTATHERA)
Closed Special Notice Posted
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Bethesda, Maryland 20889, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency's Healthcare Contracting Division Northeast issued a Special Notice on January 6, 2026, regarding the acquisition of radioactive pharmaceutical products PLUVICTO and LUTATHERA for the Department of Radiology at Walter Reed National Military Medical Center in Bethesda, Maryland. The contracting office intends to award a firm-fixed-price purchase order to Novartis Pharmaceuticals Corporation under sole source authority pursuant to FAR 6.302-1(a)(2)(iii)(b). This notice is not a competitive solicitation and no Request for Quote or formal solicitation will be issued. The estimated total contract value is $578,754.32, and the applicable NAICS code is 325412 for Pharmaceutical Preparation Manufacturing.
Interested parties have until January 11, 2026, at 7:00 AM EST to submit a capabilities statement and express their interest in the requirement, providing the government with an opportunity to evaluate whether competitive procurement should be pursued. The radioactive products must be U.S. FDA-approved and used for medical imaging of patient diseases, with Novartis currently identified as the sole FDA-approved manufacturer for both products. Eligibility is limited to firms capable of manufacturing or supplying FDA-approved PLUVICTO and LUTATHERA products. Responses will be considered solely to determine whether the government should conduct a competitive procurement, and the government retains full discretion in making this determination. Contractors should contact Malcolm Dodson, Contract Analyst, at Malcolm.dodson.ctr@health.mil with any inquiries, as phone calls will not be accepted.
Notice text
The Defense Health Agency (DHA), Healthcare Contracting Division Northeast (HCD-NE), on behalf for the Department of Radiology Department located at Walter Reed National Military Medical Center (WRNMMC), 8901 Wisconsin Avenue, Bethesda, MD 20889, under the statutory authority of the Federal Acquisition Regulation (FAR) 6.302-l(a) (2) (iii) (b), sole source, for the requirement for radioactive products (PLUVICTO and LUTATHERA) used for imaging patient’s disease, intends to award a Firm-Fixed Price, to Novartis Pharmaceuticals Corporation.
Manufactured radioactive products (PLUVICTO and LUTATHERA) used for imaging patient’s disease must be U.S. FDA Approved.
Novartis Pharmaceuticals Corporation, (CAGE: 04520), 59 Route 10, East Hanover, NJ 07936 is the FDA Approved Manufacturer for PLUVICTO and LUTATHERA. The total cost for the Purchase Order is estimated at $578,754.32. The associated NAICS code applicable to this requirement is 325412 - Pharmaceutical Preparation Manufacturer.
This notice of intent to award a competitive Purchase Order is not a request for competitive proposals. There will be no Request for Quote (RFQ) or Solicitation available for competition. Phone calls will not be accepted. This notice is not a request for competitive quotes; however, the government will consider responses to this notice within five (5) days of this posting. Interested parties, may express their interest, and provide a capabilities statement NLT January 11, 2026, at 7:00 AM EST. The point of contact for this action is Malcolm Dodson, Contract Analyst, who can be reached at Malcolm.dodson.ctr@health.mil. A determination by the government not to compete this requirement based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC | Veterans Integrated Service Network 4 | No set-aside | |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside | |
| 6505--Sources Sought Notice - Ga68 Dotatate (NETSPOT) | Veterans Integrated Service Network 17 | No set-aside | |
| 6505--VA Long Beach Pylarify | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity